RRM1 is mediated by histone acetylation through gemcitabine resistance and contributes to invasiveness and ECM remodeling in pancreatic cancer-Reference-Cited by-同舟云学术

RRM1 is mediated by histone acetylation through gemcitabine resistance and contributes to invasiveness and ECM remodeling in pancreatic cancer

Published:2023-03-02 Issue:4 Volume:62 Page:
ISSN:1019-6439
Container-title:International Journal of Oncology
language:
Short-container-title:Int J Oncol

Author:

Ono Hiroaki¹,Murase Yoshiki¹,Yamashita Hironari¹,Kato Tomotaka¹,Asano Daisuke¹,Ishikawa Yoshiya¹,Watanabe Shuichi¹,Ueda Hiroki¹,Akahoshi Keiichi¹,Ogawa Kosuke¹,Kudo Atsushi¹,Akiyama Yoshimitsu²,Tanaka Shinji²,Tanabe Minoru¹

Affiliation:

1. Department of Hepatobiliary and Pancreatic Surgery, Graduate School of Medicine, Tokyo Medical and Dental University, Tokyo 113‑8510, Japan

2. Division of Molecular Oncology, Graduate School of Medicine, Tokyo Medical and Dental University, Tokyo 113‑8510, Japan

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. YBX1 as a therapeutic target to suppress the LRP1-β-catenin-RRM1 axis and overcome gemcitabine resistance in pancreatic cancer;Cancer Letters;2024-10

2. 6:2 Cl-PFESA, a proposed safe alternative for PFOS, diminishes the gemcitabine effectiveness in the treatment of pancreatic cancer;Journal of Hazardous Materials;2024-08

3. Identification of fibronectin type III domain containing 3B as a potential prognostic and therapeutic target for pancreatic cancer: a preliminary analysis;European Journal of Medical Research;2024-04-05

4. Nicotine promotes epithelial to mesenchymal transition and gemcitabine resistance via hENT1/RRM1 signalling in pancreatic cancer and chemosensitizing effects of Embelin-a naturally occurring benzoquinone;Science of The Total Environment;2024-03

5. Histone modification and personalized epigenomics in cancer;Personalized Epigenetics;2024